Untargeted metabolomic, and proteomic analysis identifies metabolic biomarkers and pathway alterations in individuals with 22q11.2 deletion syndrome

Introduction The chromosome 22q11.2 deletion syndrome (22q11.2DS) is characterized by a well-defined microdeletion and is associated with a wide range of brain-related phenotypes including schizophrenia spectrum disorders (SCZ), autism spectrum disorders (ASD), anxiety disorders and attention defici...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Metabolomics 2024-02, Vol.20 (2), p.31-31, Article 31
Hauptverfasser:	Zafarullah, Marwa, Angkustsiri, Kathleen, Quach, Austin, Yeo, Seungjun, Durbin-Johnson, Blythe P., Bowling, Heather, Tassone, Flora
Format:	Artikel
Sprache:	eng
Schlagworte:	1-Phosphatidylinositol 3-kinase AKT protein Anxiety disorders Arachidonic acid Attention deficit hyperactivity disorder Autism Autism Spectrum Disorder - complications Autism Spectrum Disorder - genetics Biochemistry Biomarkers Biomedical and Life Sciences Biomedicine Cell Biology Chromosome 22 Chromosome deletion Clinical trials Comorbidity Complement system Developmental Biology DiGeorge Syndrome - complications DiGeorge Syndrome - diagnosis DiGeorge Syndrome - genetics Gene expression Haploinsufficiency Humans Life Sciences Longitudinal Studies Mental disorders Metabolism Metabolites Metabolomics Molecular Medicine Original Original Article Phenotypes Phosphatidylinositol 3-Kinases Proteins Proteomics Schizophrenia Signal transduction Statistical analysis Taurine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!